Israel offers advanced follicular lymphoma treatments including CAR T-cell therapy, allogeneic bone marrow transplantation, and precision immunotherapy. Academic centers like Sheba Medical Center and Sourasky Medical Center utilize molecular diagnostics to personalize drug protocols. These facilities report survival rates reaching 100% for specific patient cohorts.
- CAR-T therapy: Sheba Medical Center offers internally manufactured protocols for relapsed or refractory cases.
- Bone marrow transplant: Allogeneic and autologous transplantations are standard for high-risk or advanced stages.
- Bispecific antibodies: BiTEs like epcoritamab bridge T-cells to lymphoma cells for targeted destruction.
- Precision diagnostics: Specialists use PET/CT and molecular profiling to tailor biological therapy combinations.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center and Sourasky Medical Center manage massive patient volumes, often exceeding 400,000 annually. This high frequency allows surgeons like Dr. Arnon Nagler and Dr. Ronit El Hasid to maintain mastery in complex procedures. Their expertise is a primary reason why survival rates for certain lymphoma protocols approach 100%.
Patient Consensus: Patients often emphasize the value of `biopsy revision` in Israel, as local pathology experts frequently refine initial diagnoses. Many travelers note the comfort of 30-day hospital stays included in comprehensive bone marrow transplant packages.